| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Patents > Growing Need of Competitive Technological Intelligence |
|
Top Articles - Growing Need of Competitive Technological Intelligence
With the beginning of globalization, lower production costs and escalating production, competitiveness has become a nec According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product essity in the new information society. Knowledge has become the key corporate asset which enables companies to maintain ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in their market competitiveness. Presently, companies are involved in various types of intelligence such as competitive, lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. trategic, economic and business intelligence. Competitive Technological Intelligence is specializes in scientific here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe and technological task and it includes various operation, such as information mining, analysis and integration, thus en d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro bling informational mapping to generate information intelligence reports. These technical and competitive intelligence ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc reports are used to drive innovation and technical decisions to gain competitive supremacy. Technical intelligence easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi alerts companies for threats arising from emerging technologies that could be critical to maintain competitive position nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically . Technical intelligence provides information such as changes in competitors' technologies and business strategies, ind and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ stry trends as a whole, as well as changing market expectations and customer needs. Technical Intelligence keeps compan ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ies up to date with all the critical factors that affect the business. Patents are on of the most comprehensive source ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a of technical information, generally used to gain technical and competitive supremacy in the market. The most important dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ssue is not information collection, but intelligence use and integration of huge technical and market information into cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin easy to understand format. Advantages of Competitive Technical Intelligence tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e is no surprise - avoid being blindsided t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel thods for strategic planning to remain abreast of change in market, customers, technologies, and competitors ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rend in the core technology domains y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products , acquisition and merger opportunities Thus having the right technology and right information at the right time is . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de very important part of business success. In the current fast changing and competitive economy, companies have to get ac elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip curate and timely intelligence on their technical and competitive environment, if they want themselves to be on the top tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Inject More Approachability into Your Dental Practice Full Color Postcard Marketing: 7 Reasons Why They've Become the New Direct Mail A Simple 5-Step System To Start Affiliate Marketing Today
|